• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

技术说明:指数廓清的单点剂量估计。

Technical Note: Single time point dose estimate for exponential clearance.

机构信息

Department of Radiology, University of Iowa, Iowa City, IA, 52242, USA.

Department of Endocrinology, University of Iowa, Iowa City, IA, 52242, USA.

出版信息

Med Phys. 2018 May;45(5):2318-2324. doi: 10.1002/mp.12886. Epub 2018 Apr 16.

DOI:10.1002/mp.12886
PMID:29577338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5948162/
Abstract

OBJECTIVE

Although personalized dosimetry may be desirable for radionuclide therapy treatments, the multiple time samples required to determine the total integrated activity puts a burden on patients and clinic resources. The aim of this paper is to demonstrate that when some prior knowledge is known about the tracer kinetic parameters, the total integrated activity (and thus radiation dose) can be estimated from a single time sample.

METHODS

Mathematical derivations have been performed to generate equations for the total integrated activity in terms of a single time sample of activity for monoexponential and biexponential clearance. Simulations were performed using both exponential models where the rate constants and associated parameters were randomly sampled from distributions with a known mean. The actual total integrated activity for each random sample was compared with the estimated total integrated activity using the mean value of the parameters. Retrospective analysis of Y DOTATOC data from a clinical trial provided a comparison of actual kidney dose with the estimated kidney dose using the single time point approach.

RESULTS

The optimal sampling time for the single point approach was found to be equal to the mean time of the rate constant. The simulation results for the monoexponential and biexpoential models were similar. Regressions comparing the actual and estimated total integrated activity had very high correlations (r  > 0.95) along with acceptable standard errors of estimate, especially at the optimal sampling point. The retrospective analysis of the Y DOTATOC data also yielded similar results with an r  = 0.95 and a standard error of estimate of 61 cGy.

CONCLUSIONS

In situations where there is prior knowledge about the population averages of kinetic parameters, these results suggest that the single time point approach can be used to estimate the total integrated activity and dose with sufficient accuracy to manage radionuclide therapy. This will make personalized dosimetry much easier to perform and more available to the community.

摘要

目的

虽然放射性核素治疗可能需要个体化剂量,但确定总积分活度需要多次时间采样,这给患者和临床资源带来了负担。本文旨在证明,当对示踪剂动力学参数有一些先验知识时,可以从单个时间样本估计总积分活度(因此也可以估计辐射剂量)。

方法

对单指数和双指数清除的单一时间样本活性的总积分活度进行了数学推导,以生成方程。使用指数模型进行了模拟,其中速率常数和相关参数是从具有已知平均值的分布中随机抽样的。使用参数的平均值将每个随机样本的实际总积分活度与估计的总积分活度进行比较。对来自临床试验的 Y DOTATOC 数据的回顾性分析比较了单点方法的实际肾脏剂量和估计的肾脏剂量。

结果

发现单点方法的最佳采样时间等于速率常数的平均值。单指数和双指数模型的模拟结果相似。实际和估计的总积分活度之间的回归具有非常高的相关性(r > 0.95),并且估计值的标准误差也可以接受,尤其是在最佳采样点。Y DOTATOC 数据的回顾性分析也得到了类似的结果,r = 0.95,估计值的标准误差为 61 cGy。

结论

在具有群体动力学参数平均值先验知识的情况下,这些结果表明单点方法可用于以足够的精度估计总积分活度和剂量,从而更轻松地进行个体化剂量治疗,并使其在更广泛的范围内得到应用。

相似文献

1
Technical Note: Single time point dose estimate for exponential clearance.技术说明:指数廓清的单点剂量估计。
Med Phys. 2018 May;45(5):2318-2324. doi: 10.1002/mp.12886. Epub 2018 Apr 16.
2
Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.Y-DOTATOC 剂量学指导的个体化肽受体放射性核素治疗。
J Nucl Med. 2018 Nov;59(11):1692-1698. doi: 10.2967/jnumed.117.202903. Epub 2018 Mar 9.
3
Whole-Body Voxel-Based Personalized Dosimetry: The Multiple Voxel S-Value Approach for Heterogeneous Media with Nonuniform Activity Distributions.体素全身个性化剂量学:用于不均匀活性分布的非均匀介质的多体素 S 值方法。
J Nucl Med. 2018 Jul;59(7):1133-1139. doi: 10.2967/jnumed.117.201095. Epub 2017 Dec 14.
4
Accuracy and reproducibility of simplified QSPECT dosimetry for personalized Lu-octreotate PRRT.用于个性化镥-奥曲肽肽受体放射性核素治疗的简化QSPECT剂量测定法的准确性和可重复性。
EJNMMI Phys. 2018 Oct 15;5(1):25. doi: 10.1186/s40658-018-0224-9.
5
Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy.放射性核素治疗单次剂量测定应用的理论方面。
Phys Med Biol. 2022 Jan 19;67(2). doi: 10.1088/1361-6560/ac46e0.
6
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.基于个体化剂量测定的⁹⁰Y- DOTATOC活度降低可预防肽受体放射性核素治疗导致的严重且快速的肾功能恶化。
Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1141-57. doi: 10.1007/s00259-013-2670-x. Epub 2014 Mar 26.
7
Comparison of voxel S-value methods for personalized voxel-based dosimetry of Lu-DOTATATE.基于体素的个体化 Lu-DOTATATE 剂量计算中体素 S 值方法的比较。
Med Phys. 2022 Mar;49(3):1888-1901. doi: 10.1002/mp.15444. Epub 2022 Feb 1.
8
Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.利用(90)Y-DOTATOC预测肾毒性时的个体剂量测定:肾脏体积和剂量率在确定剂量-效应关系中的相关性。
J Nucl Med. 2005 Jan;46 Suppl 1:99S-106S.
9
Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry.将生物有效剂量扩展至医学内照射剂量学(MIRD)模式及其在放射性核素治疗剂量测定中的潜在意义。
Med Phys. 2008 Mar;35(3):1123-34. doi: 10.1118/1.2836421.
10
DOSIS: An integrated computational tool for patient-specific dosimetry in nuclear medicine by Monte Carlo and dose point kernel approaches.剂量学:一种通过蒙特卡罗方法和剂量点核方法进行核医学中患者特异性剂量测定的综合计算工具。
Appl Radiat Isot. 2019 Aug;150:135-140. doi: 10.1016/j.apradiso.2019.05.031. Epub 2019 May 24.

引用本文的文献

1
Extravasation Frequency of [Lu]Lu-DOTATATE: Insights and Implications Derived from 1,314 Cycles of Treated Patients-A Single-Site Analysis.[镥]镥-奥曲肽的外渗频率:来自1314例治疗患者周期的见解与启示——单中心分析
J Nucl Med. 2025 Aug 1;66(8):1258-1264. doi: 10.2967/jnumed.124.269411.
2
Can Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data.能否通过治疗前的生长抑素受体(SSTR)正电子发射断层扫描(PET)预测镥-奥曲肽(Lu-DOTATATE)在肾脏的吸收剂量?多中心数据研究结果
J Nucl Med. 2025 Jul 1;66(7):1082-1090. doi: 10.2967/jnumed.124.269098.
3
Accuracy and precision analyses of single-time-point dosimetry utilising physiologically-based pharmacokinetic modelling and non-linear mixed-effects modelling.利用基于生理的药代动力学模型和非线性混合效应模型对单时间点剂量测定法进行准确性和精密度分析。
EJNMMI Phys. 2025 Mar 26;12(1):26. doi: 10.1186/s40658-025-00726-7.
4
Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning.使用机器学习对即时单时间点剂量测定的有效半衰期进行表征。
J Nucl Med. 2025 May 1;66(5):778-784. doi: 10.2967/jnumed.124.268175.
5
Leveraging State-of-the-Art AI Algorithms in Personalized Oncology: From Transcriptomics to Treatment.在个性化肿瘤学中利用最先进的人工智能算法:从转录组学到治疗
Diagnostics (Basel). 2024 Sep 29;14(19):2174. doi: 10.3390/diagnostics14192174.
6
Biodosimetry, can it find its way to the nuclear medicine clinic?生物剂量测定法能进入核医学临床领域吗?
Front Nucl Med. 2023 Jul 25;3:1209823. doi: 10.3389/fnume.2023.1209823. eCollection 2023.
7
The application of radionuclide therapy for breast cancer.放射性核素疗法在乳腺癌治疗中的应用。
Front Nucl Med. 2024 Jan 10;3:1323514. doi: 10.3389/fnume.2023.1323514. eCollection 2023.
8
The University of Iowa Neuroendocrine Tumor Clinic.爱荷华大学神经内分泌肿瘤诊所。
Endocr Pract. 2025 Jan;31(1):4-18. doi: 10.1016/j.eprac.2024.09.018. Epub 2024 Sep 28.
9
Estimation of kidney doses from [Lu]Lu-DOTA-TATE PRRT using single time point post-treatment SPECT/CT.使用治疗后单时间点SPECT/CT估计[镥]镥-多柔比星-奥曲肽肽受体放射性核素治疗的肾脏剂量。
EJNMMI Phys. 2024 Jul 25;11(1):68. doi: 10.1186/s40658-024-00665-9.
10
A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?177镥剂量测定工作流程综述:如何减少成像工作量?
EJNMMI Phys. 2024 Jul 18;11(1):65. doi: 10.1186/s40658-024-00658-8.

本文引用的文献

1
Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.Y-DOTATOC 剂量学指导的个体化肽受体放射性核素治疗。
J Nucl Med. 2018 Nov;59(11):1692-1698. doi: 10.2967/jnumed.117.202903. Epub 2018 Mar 9.
2
Dose Mapping After Endoradiotherapy with Lu-DOTATATE/DOTATOC by a Single Measurement After 4 Days.4 天后单次测量进行 Lu-DOTATATE/DOTATOC 内放疗后的剂量分布。
J Nucl Med. 2018 Jan;59(1):75-81. doi: 10.2967/jnumed.117.193706. Epub 2017 Jun 6.
3
Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools.使用分子成像工具进行放射性核素治疗的个性化剂量测定
Biomedicines. 2016 Nov 15;4(4):25. doi: 10.3390/biomedicines4040025.
4
Targeted Radionuclide Therapy: Practical Applications and Future Prospects.靶向放射性核素治疗:实际应用与未来展望。
Biomark Cancer. 2016 May 18;8(Suppl 2):35-8. doi: 10.4137/BIC.S31804. eCollection 2016.
5
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.MIRD 简讯第 26 号:联合 EANM/MIRD 指南用于放射性药物治疗的定量 177Lu SPECT 应用的剂量学。
J Nucl Med. 2016 Jan;57(1):151-62. doi: 10.2967/jnumed.115.159012. Epub 2015 Oct 15.
6
Dosimetry in 131I-mIBG therapy: moving toward personalized medicine.
Q J Nucl Med Mol Imaging. 2013 Jun;57(2):161-70.
7
Personalized image-based radiation dosimetry for routine clinical use in peptide receptor radionuclide therapy: pretherapy experience.用于肽受体放射性核素治疗常规临床应用的基于图像的个性化放射剂量测定:治疗前经验
Recent Results Cancer Res. 2013;194:497-517. doi: 10.1007/978-3-642-27994-2_29.